Home
About
Overview
Sharing Data
ORCID
Help
History (11)
Stopping Clinical Trials in Inflammatory Bowel Disease During the COVID-19 Pandemic Is Not a Responsible Act.
Radiologists' performance for differentiating benign from malignant lung nodules on high-resolution CT using computer-estimated likelihood of malignancy.
Increased incidence of second neoplasms in patients treated with interferon alpha 2b for hairy cell leukemia: a clinicopathologic assessment.
A Kinase Anchor Proteins
Durability of responses to interferon alfa-2b in advanced hairy cell leukemia.
See All 11 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Durability of responses to interferon alfa-2b in advanced hairy cell leukemia.
Durability of responses to interferon alfa-2b in advanced hairy cell leukemia. Blood. 1987 Mar; 69(3):872-7.
View in:
PubMed
subject areas
Adult
Alkaline Phosphatase
Antineoplastic Agents
Blood Cell Count
Bone Marrow Diseases
Bone Marrow Examination
Combined Modality Therapy
Female
Follow-Up Studies
Humans
Interferon Type I
Leukemia, Hairy Cell
Male
Neoplasm Proteins
Neutrophils
Random Allocation
Recombinant Proteins
Splenectomy
authors with profiles
Mark Ratain
Lynne S. Kaminer
James W. Vardiman